Comparison between Intralesional Injection of Botulinum Toxin A and Triamcinolone in Management of Recent Hypertrophic Scars | ||
| Zagazig University Medical Journal | ||
| Volume 30, Issue 1.1, January and February 2024, Pages 386-395 PDF (1.04 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/zumj.2023.250902.3015 | ||
| Authors | ||
| Amr Abdallah Gomaa* 1; Mohamed Abdelmoaty Elbadawy2; Moaz Fathy Abbady3; Ahmed Mohamed Aboelnaga4 | ||
| 1Plastic surgery department, faculty of medicine, Suez Canal University | ||
| 2Plastic suergery departement, Faculty of medicine, Suez Canal Univesity | ||
| 3health insurance hospital, Suez | ||
| 4Department of surgery, fuculty of medicine, suez canal university | ||
| Abstract | ||
| Background: Hypertrophic scars lead to aesthetic and local symptoms . Moreover these scars have psychological effects such as embarrassment and low self-confidence. Many treatment modalities had been used, but each one has its limited effect. Objectives: The aim of the study is toevaluate the role of hypertrophic scars management by comparing intralesional injection of Botulinum Toxin (BTX-A) to intralesional injection of triamcinolone . Subjects and methods: This study was carried on 20 patients with hypertrophic scars, their scars were divided into two equal sectors, one sector was injected with BTX-A while the other sector was injected with corticosteroid (triamcinolone) as a control. Assessment of the results were achieved objectively and digitally photographed using the same camera, lightening setting and patient positioning before treatment, at one-month, three months and six months' visits. The hypertrophic scar score was calculated before and after treatment by patient and observer scar assessment scale (POSAS). Results: There was statistically significant improvement in both BTX-A and triamcinolone injected scars. The different parameters that assessed by POSAS showed better improvement and significant lower scores in the BTX-A injected areas without side effects. The triamcinolone injected scars showed complication such as atrophy, hypopigmentations. The results of the study revealed that BTX-A has a significant role in treatment of hypertrophic scars with minimal side effects. Conclusion: In conclusion, intralesional injection of BTX-A is suitable for treatment of recent hypertrophic scars with decreasing associated pain and itching and better tolerated than corticosteroid. | ||
| Keywords | ||
| Keywords: Botulinum Toxin A; Triamcinolone; Hypertrophic Scars | ||
|
Statistics Article View: 181 PDF Download: 587 |
||
